Published in Nature on March 29, 1979
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol (1991) 0.87
Effects of thyrotrophin-releasing hormone, and methionine-enkephalin on gastric acid and pepsin secretion in the cat. Br J Pharmacol (1980) 0.78
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) (2000) 5.19
The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci (2001) 5.18
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev (1997) 3.80
Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci (1996) 3.66
Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci (2000) 3.19
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend (1998) 2.71
Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience (1991) 2.58
Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem (1999) 1.86
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience (1999) 1.80
Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience (1998) 1.70
Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci (2001) 1.65
Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther (1998) 1.54
Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology (2000) 1.50
Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav (2005) 1.43
Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci (1997) 1.37
Opioid receptor subtypes that mediate a microwave-induced decrease in central cholinergic activity in the rat. Bioelectromagnetics (1992) 1.36
Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci (1994) 1.27
The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition. Biochem Pharmacol (1968) 1.24
NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci (2000) 1.23
Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids (2002) 1.23
Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther (1995) 1.22
Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci (1992) 1.17
The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther (1999) 1.17
Repeated cocaine administration alters the electrophysiological properties of prefrontal cortical neurons. Neuroscience (2002) 1.15
Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res (1991) 1.14
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo. Biochem Pharmacol (1969) 1.11
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro. Biochem Pharmacol (1969) 1.10
Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience (2006) 1.10
Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis (2001) 1.10
Cardiac monoamine oxidase in rat. Nature (1967) 1.09
Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J Pharmacol Exp Ther (1987) 1.05
Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience (1998) 1.05
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther (1983) 1.05
Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther (2000) 1.04
Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol (1982) 1.03
Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience (1993) 1.03
The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation. Neuroscience (1995) 1.02
Computational model of extracellular glutamate in the nucleus accumbens incorporates neuroadaptations by chronic cocaine. Neuroscience (2008) 1.01
Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem (1999) 1.01
Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience (1999) 1.01
Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl) (1994) 1.00
Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology (Berl) (1996) 1.00
Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse (1997) 1.00
Pharmacology of thyrotropin-releasing hormone. Annu Rev Pharmacol Toxicol (1986) 0.99
Annular elastolytic giant cell granuloma associated with prostate carcinoma: demonstration of human metalloelastase (MMP-12) expression. Clin Exp Dermatol (2011) 0.99
NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci (1997) 0.97
The stress dependent nature of apomorphine hyperthermia in the rabbit. Proc West Pharmacol Soc (1975) 0.97
Thyrotropin-releasing hormone: stimulation of colonic activity following intracerebroventricular administration. Science (1977) 0.96
Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance. Neuropharmacology (1985) 0.96
Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res (1989) 0.96
Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther (1997) 0.96
Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience (1983) 0.96
Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther (1996) 0.95
Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther (1993) 0.95
Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. J Pharmacol Exp Ther (1983) 0.95
Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience (1992) 0.95
Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem Res (1992) 0.94
Sensitization to stress and psychostimulants. Involvement of dopamine transmission versus the HPA axis. Ann N Y Acad Sci (1995) 0.93
Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience (1984) 0.92
The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology (Berl) (1997) 0.92
Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther (1991) 0.92
The mediodorsal nucleus of the thalamus in rats--I. forebrain gabaergic innervation. Neuroscience (1996) 0.91
Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats. Behav Brain Res (2005) 0.90
Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav Brain Res (2001) 0.90
A topographically organized gamma-aminobutyric acid projection from the ventral pallidum to the nucleus accumbens in the rat. J Comp Neurol (1994) 0.90
Microwave irradiation affects radial-arm maze performance in the rat. Bioelectromagnetics (1994) 0.90
Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav (1995) 0.90
Effect of propranolol on the blockade of alpha adrenergic receptors. J Pharmacol Exp Ther (1968) 0.89
Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience (1995) 0.89
Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res (1987) 0.89
Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res (1990) 0.89
The mediodorsal nucleus of the thalamus in rats--II. Behavioral and neurochemical effects of GABA agonists. Neuroscience (1996) 0.89
Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther (1994) 0.88
Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res (1987) 0.88
The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Brain Res (1988) 0.88
Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther (1982) 0.87
Low-level microwave irradiations affect central cholinergic activity in the rat. J Neurochem (1987) 0.87
Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther (1990) 0.87
Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse (1995) 0.87
Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol Psychiatry (1986) 0.87
Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther (2001) 0.86
Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J Pharmacol Exp Ther (1996) 0.86
Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res (1992) 0.86
Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat. J Pharmacol Exp Ther (1980) 0.86
Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res (1985) 0.86
Neuropharmacology of addiction--setting the scene. Br J Pharmacol (2008) 0.85
Centrally administered thyrotropin-releasing hormone (TRH) stimulates colonic transit and diarrhea production by a vagally mediated serotonergic mechanism in the rabbit. J Pharmacol Exp Ther (1982) 0.85
Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci (1982) 0.85
Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther (1987) 0.84
AGS3: a G-Protein regulator of addiction-associated behaviors. Ann N Y Acad Sci (2003) 0.84
Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther (1990) 0.84
Chlordiazepoxide displaces thyrotropin-releasing hormone (TRH) binding. Eur J Pharmacol (1984) 0.84
The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry (1992) 0.84
Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Jpn J Pharmacol (1989) 0.84
Receptor binding and characterization of TRH receptors. Ann N Y Acad Sci (1989) 0.83
Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits. Psychopharmacol Commun (1975) 0.83
High sensitivity HPLC assay for GABA in brain dialysis studies. J Neurosci Methods (1991) 0.82